收藏切换
Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiota
收藏切换
PDF
Yan LI, Wei-ze ZHU, Hou-kai LI*
Acta Pharmaceutica Sinica | 2022, 57(12) : 3451 - 3464
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(12): 3451-3464
Special Reports: Therapeutic Modulation of Gut Immune and Microbiota Homeostasis by Chinese Medicine
Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiota
Full
Yan LI, Wei-ze ZHU, Hou-kai LI*
Affiliations
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Published: 2022-12-12 doi: 10.16438/j.0513-4870.2022-0605
Outline
收藏切换

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. However, due to its complex pathogenesis, there are no officially approved drugs for NAFLD treatment currently. Therefore, it is extremely urgent to find safe and effective anti-NAFLD drugs. Nowadays, lipid-lowering drugs are the main option for NAFLD therapy, but the clinical efficacy of chemical drugs is also very limited, as well as the frequent side effects or adverse reactions. Traditional Chinese medicine (TCM) has attracted more and more attention in the treatment of NAFLD due to its unique advantages through multiple targets and pathways with few side effects. In recent years, numerous studies have demonstrated that the imbalance of gut microbiota plays an important role in the occurrence and development of NAFLD. This review systematically summarizes the experimental and clinical evidences of TCM active compounds and TCM prescription involved in the regulation of intestinal flora in the treatment of NAFLD in recent years, so as to provide a reference for further exploring the pathogenesis of NAFLD and exploring TCM treatment methods.

gut microbiota  /  non-alcoholic fatty liver disease  /  gut-liver axis  /  traditional Chinese medicine  /  metabolism
Yan LI, Wei-ze ZHU, Hou-kai LI. Research progress of traditional Chinese medicine formulas and active compounds in the treatment of non-alcoholic fatty liver disease by regulating gut microbiota[J]. Acta Pharmaceutica Sinica, 2022 , 57 (12) : 3451 -3464 . DOI: 10.16438/j.0513-4870.2022-0605
Year 2022 volume 57 Issue 12
PDF
244
104
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0605
  • Receive Date:2022-05-19
  • Online Date:2025-12-24
  • Published:2022-12-12
Article Data
Affiliations
History
  • Received:2022-05-19
  • Revised:2022-08-15
Funding
Affiliations
    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0605
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT